Content-type: text/html Suchergebnis - Abbildungen und Graphiken
Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Mobile Version
A-  |   A  |   A+
Werbung
 
Suchergebnis - Abbildungen und Graphiken
 
Alle Journale wurden nach Schramm GAK durchsucht Treffer 1 - 6 von 6

Medizinische Publikationen (1)  ::   Abbildungen und Graphiken  ::   Volltext (0)

Neue Suche:         Erweiterte Suche    Hilfe zur Suche

in allen Journalen nach  Bildtitel    Bildkeywords   Bildsummary   Autoren      Mindestens ein Wort  Alle Wörter   
1. Schramm GAK; Waldmann-Rex S
Effects of 2 mg Chlormadinone Acetate/0.03 mg Ethinylestradiol in Primary Dysmenorrhoea: The BEDY (Belara(R) Evaluation on Dysmenorrhea) Study - an Open, Non-Comparative, Non-Interventional Observational Study with 4,842 Women
BEDY Study - Cycle-Related Disorders
Journal für Reproduktionsmedizin und Endokrinologie - Journal of Reproductive Medicine and Endocrinology 2010; 7 (Sonderheft 1): 112-118
Incidence of moderate to severe symptoms in other cycle-related disorders, before and after the administration of 2 mg chlormadinone acetate/0.03 mg ethinylestradiol (CMA/EE). Results from patients with valid ratings at baseline and after 6 cycles/blister packs of CMA/EE treatment are shown.

Keywords: Kontrazeption
Artikel:
Volltext (PDF)
Summary
Abbildungen
BEDY Study - Cycle-Related Disorders

Detailansicht
2. Schramm GAK; Waldmann-Rex S
Effects of 2 mg Chlormadinone Acetate/0.03 mg Ethinylestradiol in Primary Dysmenorrhoea: The BEDY (Belara(R) Evaluation on Dysmenorrhea) Study - an Open, Non-Comparative, Non-Interventional Observational Study with 4,842 Women
BEDY Study - Skin and Hair Symptoms
Journal für Reproduktionsmedizin und Endokrinologie - Journal of Reproductive Medicine and Endocrinology 2010; 7 (Sonderheft 1): 112-118
Incidence and intensity of skin and hair symptoms, before and after the administration of 2 mg chlormadinone acetate/0.03 mg ethinylestradiol (CMA/EE). Results from patients with valid ratings at baseline and after 6 cycles/blister packs of CMA/EE treatment are shown (n = 3951, Acne Prone Skin; n = 3934, Greasy Hair).

Keywords: Kontrazeption
Artikel:
Volltext (PDF)
Summary
Abbildungen
BEDY Study - Skin and Hair Symptoms

Detailansicht
3. Schramm GAK; Waldmann-Rex S
Effects of 2 mg Chlormadinone Acetate/0.03 mg Ethinylestradiol in Primary Dysmenorrhoea: The BEDY (Belara(R) Evaluation on Dysmenorrhea) Study - an Open, Non-Comparative, Non-Interventional Observational Study with 4,842 Women
BEDY Study - Dysmenorrhoea
Journal für Reproduktionsmedizin und Endokrinologie - Journal of Reproductive Medicine and Endocrinology 2010; 7 (Sonderheft 1): 112-118
Absence from school or work due to dysmenorrhoea, before and after the administration of 2 mg chlormadinone acetate/0.03 mg ethinylestradiol (CMA/EE). Results from patients with valid ratings at baseline and after 6 cycles/blister packs of CMA/EE treatment are shown (n = 3722).

Keywords: Kontrazeption
Artikel:
Volltext (PDF)
Summary
Abbildungen
BEDY Study - Dysmenorrhoea

Detailansicht
4. Schramm GAK; Waldmann-Rex S
Effects of 2 mg Chlormadinone Acetate/0.03 mg Ethinylestradiol in Primary Dysmenorrhoea: The BEDY (Belara(R) Evaluation on Dysmenorrhea) Study - an Open, Non-Comparative, Non-Interventional Observational Study with 4,842 Women
BEDY Study - Analgesic Treatment
Journal für Reproduktionsmedizin und Endokrinologie - Journal of Reproductive Medicine and Endocrinology 2010; 7 (Sonderheft 1): 112-118
Incidence and frequency of analgesic treatment due to dysmenorrhoea, before and after the administration of 2 mg chlormadinone acetate/0.03 mg ethinylestradiol (CMA/EE). Results from patients with valid ratings at baseline and after 6 cycles/blister packs of CMA/EE treatment are shown (n = 3860).

Keywords: Kontrazeption
Artikel:
Volltext (PDF)
Summary
Abbildungen
BEDY Study - Analgesic Treatment

Detailansicht
5. Schramm GAK; Waldmann-Rex S
Effects of 2 mg Chlormadinone Acetate/0.03 mg Ethinylestradiol in Primary Dysmenorrhoea: The BEDY (Belara(R) Evaluation on Dysmenorrhea) Study - an Open, Non-Comparative, Non-Interventional Observational Study with 4,842 Women
BEDY Study - Dysmenorrhoea
Journal für Reproduktionsmedizin und Endokrinologie - Journal of Reproductive Medicine and Endocrinology 2010; 7 (Sonderheft 1): 112-118
Intensity of dysmenorrhoea symptoms before and after the administration of 2 mg chlormadinone acetate/ 0.03 mg ethinylestradiol (CMA/EE). Results from patients with valid ratings at baseline and after 6 cycles/blister packs of CMA/EE treatment are shown (n = 3857).

Keywords: Kontrazeption
Artikel:
Volltext (PDF)
Summary
Abbildungen
BEDY Study - Dysmenorrhoea

Detailansicht
6. Schramm GAK; Waldmann-Rex S
Effects of 2 mg Chlormadinone Acetate/0.03 mg Ethinylestradiol in Primary Dysmenorrhoea: The BEDY (Belara(R) Evaluation on Dysmenorrhea) Study - an Open, Non-Comparative, Non-Interventional Observational Study with 4,842 Women
BEDY-Study - Age distribution
Journal für Reproduktionsmedizin und Endokrinologie - Journal of Reproductive Medicine and Endocrinology 2010; 7 (Sonderheft 1): 112-118
Age distribution of women in the efficacy sample (n = 4514).

Keywords: Kontrazeption
Artikel:
Volltext (PDF)
Summary
Abbildungen
BEDY-Study - Age distribution

Detailansicht
 

 Seite 1 von 1 
 
 
copyright © 2000–2026 Krause & Pachernegg GmbH | Sitemap | Datenschutz | Impressum
 
Werbung